Renal denervation in 2025: long-term evidence supporting sympathetic modulation as a durable strategy for uncontrolled hypertension
These data support RDN as a potentially durable and safe adjunctive therapy for uncontrolled hypertension in appropriately selected patients. Benefits appear to extend to high-risk populations including patients with diabetes, chronic kidney disease, and prior stroke, though long-term cardiovascular outcome data remain awaited.
Authors
- François Bronner
- Elena‐Mihaela Cordeanu (ORCID: https://orcid.org/0000-0002-5502-542X)
- Éric Prinz
- Mihaela Calcainu
- Emma Morisot
- Dominique Stephan
Institutions
- Hôpitaux Universitaires de Strasbourg (FR)
- Groupe Hospitalier de la Région de Mulhouse et Sud Alsace (FR)
Publication Details
- Journal
- International Journal of Cardiology Cardiovascular Risk and Prevention
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1016/j.ijcrp.2026.200587
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00